منابع مشابه
Oral Anti-diabetic Agents as an Alternative Treatment of Diabetes in Pregnancy
Diabetes is the commonest medical condition in pregnancy. The initial treatment of gestational and Type 2 diabetes in pregnancy is dietary and lifestyle measures. Upon failure of this, pharmacological treatment is advocated which is insulin due to its unparalleled efficacy and safety. But insulin has got some drawbacks like suboptimal patient adherence specially in developing countries. Conside...
متن کاملPrevalence of Anti Hyperglycemic Agents -Associated Oral Lichenoid Lesions in Type 2 Diabetes Mellitus Patients
Objective: This study aimed to estimate the prevalence of lichenoid reactions to Anti Hyperglycemic Agents. Materials and Methods: In this cross-sectional descriptive and analytic study, we examined the oral mucosa of 411 patients at the age of 29 to 85 in 3 groups who consumed various antihyperglycemic agents. Results: In overall, 31 patients had lichenoid reactions (12 patients taking glibe...
متن کاملA study of the anti-diabetic agents of camel milk.
The number of people diagnosed with type 2 diabetes has risen steeply recently exhausting the ability of health care systems to deal with the epidemic. Seventy-five percent of people with diabetes live in low- and middle-income countries. The largest populations of diabetics are in China and India, with many of those people living in extreme pover...
متن کاملSmall molecule glucokinase activators as novel anti-diabetic agents.
The monomeric enzyme GK (glucokinase) has a low affinity for glucose and, quantitatively, is largely expressed in the liver and pancreatic beta-cells, playing a key 'glucose sensing' role to regulate hepatic glucose balance and insulin secretion. Mutations of GK in man can be inactivating, to cause a form of diabetes mellitus, or activating, to lower blood glucose levels. Recently, models of GK...
متن کاملAnti-vascular endothelial growth factor agents for diabetic maculopathy.
The management of diabetic macular oedema is changing. The therapeutic armamentarium for diabetic macular oedema (DMO) includes a new group of drugs that inhibit vascular endothelial growth factor (VEGF). These anti-VEGF agents are already being used widely in DMO in clinical practice despite that several phase III trials on these drugs are still underway. There are no established protocols on ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Bangladesh Medical Journal
سال: 2017
ISSN: 2219-1607,0301-035X
DOI: 10.3329/bmj.v45i3.33143